 |
submitted by /u/DoremusJessup [link] [comments] |
The US drug regulator on Thursday said only people with mild dementia should receive the first new Alzheimer's medicine in decades, after facing intense backlash from many in the medical community over its authorization
The US drug regulator on Thursday said only people with mild dementia should receive the first new Alzheimer's medicine in decades, after facing intense backlash from many in the medical community over its authorization
https://ift.tt/36rRh2l July 09, 2021 at 04:38AM https://ift.tt/1R552o9
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment